Growth Metrics

Axsome Therapeutics (AXSM) Amortizatization of Intangibles (2022 - 2026)

Axsome Therapeutics' Amortizatization of Intangibles history spans 5 years, with the latest figure at $1.6 million for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 135.68% to $1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 million, a 70.08% decrease, with the full-year FY2025 number at $1.3 million, down 79.62% from a year prior.
  • Amortizatization of Intangibles hit $1.6 million in Q1 2026 for Axsome Therapeutics, up from -$330000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for AXSM hit a ceiling of $5.7 million in Q4 2024 and a floor of -$330000.0 in Q4 2025.
  • Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $1.6 million in 2023.
  • Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 1154.41% in 2024 and later plummeted 105.79% in 2025.
  • Tracing AXSM's Amortizatization of Intangibles over 5 years: stood at $1.6 million in 2022, then plummeted by 71.75% to $454000.0 in 2023, then skyrocketed by 1154.41% to $5.7 million in 2024, then crashed by 105.79% to -$330000.0 in 2025, then soared by 576.36% to $1.6 million in 2026.
  • Business Quant data shows Amortizatization of Intangibles for AXSM at $1.6 million in Q1 2026, -$330000.0 in Q4 2025, and $684000.0 in Q3 2025.